Press releases
- Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- Edwards Lifesciences to Sell Critical Care to BD
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
More ▼
Key statistics
On Friday, EDWARDS LIFEDRN (E1WL34:SAO) closed at 116.22, -3.25% below its 52-week high of 120.12, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 116.22 |
---|---|
High | 116.22 |
Low | 116.22 |
Bid | -- |
Offer | -- |
Previous close | 115.32 |
Average volume | 13.63 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 07 2024 20:54 BST.
More ▼